enalkiren has been researched along with cgp 38560a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Connolly, CJ; Doherty, AM; Hamilton, HW; Klutchko, SR; Patt, WC; Ryan, MJ; Sircar, I; Steinbaugh, BA; Taylor, DG; Taylor, MD | 1 |
| Brennan, ST; Himmelsbach, RJ; Hodges, JC; Humblet, CC; Hurley, TR; Kaltenbronn, JS; Lunney, E; Repine, JT; Sircar, I; Skeean, RW | 1 |
2 other study(ies) available for enalkiren and cgp 38560a
| Article | Year |
|---|---|
Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors.
Topics: Animals; Blood Pressure; Cathepsin D; Dogs; Enzyme Inhibitors; Enzyme Stability; Humans; Macaca fascicularis; Male; Rats; Renin; Species Specificity; Structure-Activity Relationship; Thiazoles | 1992 |
Renin inhibitors containing esters at the P2-position. Oral activity in a derivative of methyl aminomalonate.
Topics: Administration, Oral; Animals; Blood Pressure; Cathepsin D; Dipeptides; Enzyme Inhibitors; Esters; Humans; Hypertension, Renal; Imidazoles; Macaca fascicularis; Models, Molecular; Morpholines; Oligopeptides; Renin; Stereoisomerism; Structure-Activity Relationship | 1991 |